2016
DOI: 10.1038/srep39305
|View full text |Cite
|
Sign up to set email alerts
|

Pharmacological and genetic reappraisals of protease and oxidative stress pathways in a mouse model of obstructive lung diseases

Abstract: Protease-antiprotease imbalance and oxidative stress are considered to be major pathophysiological hallmarks of severe obstructive lung diseases including chronic obstructive pulmonary disease (COPD) and cystic fibrosis (CF), but limited information is available on their direct roles in the regulation of pulmonary phenotypes. Here, we utilized βENaC-transgenic (Tg) mice, the previously established mouse model of severe obstructive lung diseases, to produce lower-mortality but pathophysiologically highly useful… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

2
29
0

Year Published

2018
2018
2020
2020

Publication Types

Select...
7

Relationship

3
4

Authors

Journals

citations
Cited by 21 publications
(31 citation statements)
references
References 65 publications
2
29
0
Order By: Relevance
“…Total RNA was isolated from cells and mouse lung tissues using the RNAiso Plus Kit (Takara) and cDNA synthesis was performed using the PrimeScript RT Regent Kit (Takara). Real-time quantitative RT-PCR analysis was performed as described previously ( Shuto et al, 2016 ). α-, β-, and γ-ENaC-expression plasmids (pCMV-Tag5A) were produced previously ( Sugahara et al, 2009 ) and used to measure the total amounts of mRNA.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…Total RNA was isolated from cells and mouse lung tissues using the RNAiso Plus Kit (Takara) and cDNA synthesis was performed using the PrimeScript RT Regent Kit (Takara). Real-time quantitative RT-PCR analysis was performed as described previously ( Shuto et al, 2016 ). α-, β-, and γ-ENaC-expression plasmids (pCMV-Tag5A) were produced previously ( Sugahara et al, 2009 ) and used to measure the total amounts of mRNA.…”
Section: Methodsmentioning
confidence: 99%
“…Indeed, the expression and function of ENaC were inversely associated with lung function in CF patients ( Boucher, 2007 ). Moreover, we and others have reported that mice with airway-specific overexpression of βENaC (βENaC-transgenic [Tg] mice) exhibit the critical pulmonary phenotypes of CF, such as mucus obstructive, airway inflammatory, and emphysematous phenotypes ( Mall et al, 2004 , Johannesson et al, 2012 , Shuto et al, 2016 ). These findings imply that CFTR and ENaC are essential ion transporters that control airway fluid homeostasis.…”
Section: Introductionmentioning
confidence: 99%
“…ENaC overexpression/hyperactivation is an important hallmark in the pathogenesis of many types of lung diseases, such as COPD and CF, [4][5][6] and causes impaired mucociliary clearance in the airway. Improvement of "mucostasis," a complication in patients having defects in mucociliary clearance, by targeting ENaC is now widely accepted in the pulmonary research field.…”
Section: Discussionmentioning
confidence: 99%
“…3) Importantly, hyperactivation of ENaC was correlated with lung dysfunction in patients with cystic fibrosis (CF), 4) a common genetic disorder in Caucasians. Moreover, ENaC were also dysregulated in patients with chronic obstructive pulmonary disease (COPD), 5,6) a lung disease that exhibits inflammatory, emphysematous and mucus hypersecretory phenotypes. Consistently, airway-specific βENaC-transgenic (Tg) mice show mucus obstructive lung phenotypes like CF and COPD, 7,8) implying that constitutive and hyperactive ENaC is being recog-nized as therapeutic targets; however, the agents that suppress ENaC are yet to be clinically available.…”
Section: Introductionmentioning
confidence: 99%
“…A real-time quantitative reverse transcription (RT)-polymerase chain reaction (PCR) analysis. Quantitative RT-PCR was performed by protocols that were previously reported 37 . After reverse transcription, we performed real-time PCR with iQ5 (Bio-Rad) in a mix containing DNA polymerase and SYBR Green (PR820; Takara Bio, Inc., Shiga, Japan).…”
Section: Methodsmentioning
confidence: 99%